<SEC-DOCUMENT>0001628280-24-010965.txt : 20240313
<SEC-HEADER>0001628280-24-010965.hdr.sgml : 20240313
<ACCEPTANCE-DATETIME>20240313170450
ACCESSION NUMBER:		0001628280-24-010965
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20240313
DATE AS OF CHANGE:		20240313

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		24746894

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>a2023proxy-defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ib1da384b852b4848bbf87a76ab2edfbd_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON,&#160;DC 20549</font></div><div style="margin-bottom:4pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SCHEDULE&#160;14A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section&#160;14(a) of</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> the Securities Exchange Act of 1934</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant&#160;</font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font></div><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box&#58;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Preliminary Proxy Statement</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Definitive Proxy Statement</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Definitive Additional Materials</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;Soliciting Material Pursuant to &#167;240.14a-12</font></div><div style="margin-top:7pt;padding-left:3.37pt;padding-right:3.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of Filing Fee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> (Check the appropriate box)&#58;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.047%"><tr><td style="width:1.0%"></td><td style="width:3.963%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.837%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required.</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o&#160;&#160;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table below per Exchange Act Rules&#160;14a-6(i)(1) and 0-11.</font></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class of securities to which transaction applies&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate number of securities to which transaction applies&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule&#160;0-11 (set forth the amount on which the filing fee is calculated and state how it was determined)&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proposed maximum aggregate value of transaction&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:470.25pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:448.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fee paid&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.327%"><tr><td style="width:1.0%"></td><td style="width:5.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Check box if any part of the fee is offset as provided by Exchange Act Rule&#160;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:420.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:397.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount previously paid&#58;</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:420.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:397.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form, Schedule or Registration Statement No.&#58;</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:420.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:397.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filing Party&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:420.00pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:397.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date Filed&#58;</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</font></div></div></div><div id="ib1da384b852b4848bbf87a76ab2edfbd_96"></div><hr style="page-break-after:always"><div style="min-height:9pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><img alt="cumberlandlogoa02a01.jpg" src="cumberlandlogoa02a01.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:316px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a shareholder of Cumberland Pharmaceuticals Inc. you have the option of voting your shares electronically through the Internet, eliminating the need to return the proxy card.  Your electronic vote authorizes the named proxies to vote your shares in the same manner as if you marked, signed, dated and returned the proxy card.  Votes submitted electronically over the Internet or by mobile device must be received by 11&#58;59 p.m., Eastern Time, on April 22, 2024.</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.134%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Vote Your Proxy on the Internet&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Vote Your Proxy on your Mobile&#58;</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Vote Your Proxy via the mail&#58;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">OR</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">OR</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Go to www.cstproxyvote.com</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Have your proxy card available when you access the above website.  Follow the prompts to vote your shares.</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On your Smartphone&#47;Tablet, open the QR Reader and scan the below image. Once the voting site is displayed, enter your Control Number from the proxy card and vote your shares.</font></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark, sign, and date your proxy card, then detach it, and return it in the postage-paid envelope provided.</font></td></tr><tr style="height:27pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:372.00pt"><tr><td style="width:1.0pt"></td><td style="width:370.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE DO NOT RETURN THE PROXY CARD IF YOU ARE</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;VOTING ELECTRONICALLY OR BY PHONE</font></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#218;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FOLD AND DETACH HERE AND READ THE REVERSE SIDE </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#218;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.871%"><tr><td style="width:1.0%"></td><td style="width:27.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.676%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.554%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">This Proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder. If no direction is made, this Proxy will be voted FOR Proposals 1 AND 2.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"><div style="text-align:center"><img alt="xa01.jpg" src="xa01.jpg" style="height:33px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Against</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Abstain</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1. For the election as directors of the nominees listed below, except to the extent that authority is specifically withheld.</font></div><div><font><br></font></div><div style="padding-left:63pt"><font><br></font></div><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">FOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> all Nominees listed to the left</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">WITHHOLD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">AUTHORITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> to vote (except as marked to the contrary for all nominees listed to the left</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2. To ratify the appointment of Carr, Riggs &#38; Ingram, LLC as independent registered accounting firm of the Company for fiscal year ending December 31, 2024.</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:20pt;font-weight:700;line-height:100%">o</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:20pt;font-weight:700;line-height:100%">o</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:20pt;font-weight:700;line-height:100%">o</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NOMINEES&#58;                                                          (1)   Martin S. Brown, Jr.                                        (2)   James R. Jones                                   </font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:20pt;font-weight:700;line-height:100%">o</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:20pt;font-weight:700;line-height:100%">o</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(INSTRUCTION&#58; To withhold authority to vote for any individual nominee, write that nominee's name on the space provided below.)</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting.</font></td></tr><tr><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">I understand that I may revoke this Proxy only by&#58; (i) written instructions to that effect, signed and dated by me, which must be actually received by the Corporate Secretary prior to the commencement of the Annual Meeting&#59; (ii) properly submitting to the Company a duly executed proxy bearing a later date&#59; OR (iii) appearing at the Annual Meeting and voting in person.</font></td></tr></table></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.102%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPANY ID&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PROXY NUMBER&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACCOUNT NUMBER&#58;</font></td></tr></table></div><div style="padding-left:4.5pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Signature  _________________________________ Signature if Held Jointly____________________________________ Date____________ , 2024. </font></div><div style="padding-left:4.5pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">Please sign exactly as your name appears on your stock certificate. When shares are held by joint tenants, both should sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as such. If the </font></div><div style="padding-left:4.5pt;padding-right:6.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">shares are owned by a corporation, sign in the full corporate name by the President or other authorized officer. If the shares are owned by a Partnership, sign in the name of the Partnership name by an authorized person.</font></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</font></div></div></div><div id="ib1da384b852b4848bbf87a76ab2edfbd_112"></div><hr style="page-break-after:always"><div style="min-height:31.5pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font><br></font></div><div style="margin-top:0.4pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held April 23, 2024</font></div><div style="margin-top:0.6pt"><font><br></font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">   The Notice, Proxy Statement, and our Annual Report on Form 10-K for the year ended December&#160;31, 2023 are available at&#58; </font></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">http&#58;&#47;&#47;www.cstproxy.com&#47;cumberlandpharma&#47;2024</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9660; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">FOLD AND DETACH HERE AND READ THE REVERSE SIDE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9660;</font></div><div><font><br></font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">To Be Held April 23, 2024</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-right:11.25pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned hereby appoints A.J. Kazimi and Kenneth J. Krogulski, or either of them, as proxies, with full power of substitution, and hereby authorizes each of them to represent and vote, as designated on the reverse side, all of the shares of Common Stock of Cumberland Pharmaceuticals Inc., held of record by the undersigned on March 1, 2024 at the Annual Meeting of Shareholders to be held at the Cumberland Pharmaceuticals Inc., 1600 West End Avenue, Suite 1300, Nashville, Tennessee 37203 on Tuesday, April 23, 2024, at 9&#58;30 a.m. Central Time, or any adjournment(s) or postponement(s) thereof, with all powers which the undersigned would possess if personally present, upon and in respect of the following matters and in accordance with the instructions specified on the reverse side.</font></div><div><font><br></font></div><div style="padding-right:11.25pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTIONS ARE GIVEN, THIS PROXY WILL BE VOTED FOR ALL OF THE DIRECTOR NOMINEES NAMED IN PROPOSAL 1 ON THE REVERSE SIDE AS WELL AS PROPOSAL 2. THE PROXIES NAMED ABOVE ARE HEREBY AUTHORIZED TO VOTE IN THEIR DISCRETION UPON SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING AND ANY ADJOURNMENT(S) OR POSTPONEMENT(S) THEREOF.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.65pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Continued, and to be marked, dated and signed, on the other side)</font></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>cumberlandlogoa02a01.jpg
<TEXT>
begin 644 cumberlandlogoa02a01.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !: 8P# 2(  A$! Q$!_\0
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MQI5+7WDVM6_R79"J0DXJ53>\?S/T _X*C_\ *,_]HK_LF/B3_P!-5S7XQ_\
M!'7QA^W?H/[(,EO^S+X4^&>L_#K_ (2&]>:X\020K>_V@5C^T+\]S'\@^3;\
MM?L__P %.+*;4O\ @FU^T%:V\,MQ<W/PV\10Q0Q(99)';2[D*JJ.22:_%?\
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M_E.BE[;Z;9$_NHE?G#\2OV=?'_[.%WY'COP9KGAA$?;]LFM_/TY_I=1[H/\
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MI;=XUV[8)=/;YC*6K)4FX.?]6ZOY#<M;'U;117Y+ZK^V/:Z=\>_C<WQ*^/\
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M?@_XR\6:O?>(/$7B'0EN;[4;T)]HNW\V1=S[%"YP!TJI82<:3JRTL[6Z]?\
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M)A:5"C"<92E.UO)[72_4)2DGHKGZ#T45\P?LE?%_Q/XZ_;V_:P\,ZQK5U?\
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80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>xa01.jpg
<TEXT>
begin 644 xa01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R '<# 2(  A$! Q$!_\0
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M]8TI)C%I-P99+QB\\3S&*8%]ZDR(8C(YY4;F1E(!=O0/!VN7'B+0_P"T;GR
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40 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
